BCL9 and neoplasm: Furthermore, we demonstrated that TAK1/NF-κB/IRF1 signaling was also activated in cDC1 from TdLNs of MC38 tumor-bearing Bcl9/Bcl9l deficiency mice using multiplex immunofluorescence (Supplementary Fig. 11a).